Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5800
-0.0249 (-4.12%)
At close: Jul 27, 2026
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $41.09 million as of July 28, 2026. Its market cap has decreased by -47.76% in one year.
Market Cap
41.09M
Enterprise Value
42.74M
Revenue
113.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.58
ChartMarket Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 41.09M, an increase of 22.21%. That is a compound annual growth rate of 1.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 39.40M | -33.36% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 85.98M |
| BioStem Technologies | 71.08M |
| Nuo Therapeutics | 49.38M |
| Vicapsys Life Sciences | 47.26M |
| Cell Source | 44.16M |
| ProText Mobility | 36.92M |
| Sangamo Therapeutics | 26.93M |
| EOM Pharmaceuticals Holdings | 26.41M |